Your browser doesn't support javascript.
loading
Low expression of MEOX2 is associated with poor survival in patients with breast cancer.
Wang, Huxia; Tang, Yanan; Wang, Meixia; Zhao, Jing; Ding, Caixia; Yang, Xiaomin; Han, Pihua; Liu, Peijun.
Afiliación
  • Wang H; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
  • Tang Y; Department of Mammary, Shaanxi Provincial Cancer Hospital, Xi'an, 710061, China.
  • Wang M; Department of Vascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
  • Zhao J; Department of Health Examination, Shenmu Hospital, Yulin, 719300, China.
  • Ding C; Department of Mammary, Shaanxi Provincial Cancer Hospital, Xi'an, 710061, China.
  • Yang X; Department of Pathology, Shaanxi Provincial Cancer Hospital, Xi'an, 710061, China.
  • Han P; Department of Mammary, Shaanxi Provincial Cancer Hospital, Xi'an, 710061, China.
  • Liu P; Department of Mammary, Shaanxi Provincial Cancer Hospital, Xi'an, 710061, China.
Biomark Med ; 16(16): 1161-1170, 2022 11.
Article en En | MEDLINE | ID: mdl-36625258
In this study we found that lower expression of the protein MEOX2 was associated with poor overall survival in breast cancer. MEOX2 is an independent prognostic factor for breast cancer patients. It would be a new diagnostic and prognostic biomarker for breast cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China